215 related articles for article (PubMed ID: 15200439)
1. Chronic kidney disease: the distribution of health care dollars.
St Peter WL; Khan SS; Ebben JP; Pereira BJ; Collins AJ
Kidney Int; 2004 Jul; 66(1):313-21. PubMed ID: 15200439
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
[TBL] [Abstract][Full Text] [Related]
3. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
[TBL] [Abstract][Full Text] [Related]
4. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.
Collins AJ
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii2-6. PubMed ID: 12819293
[TBL] [Abstract][Full Text] [Related]
5. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
Khan S
Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
[TBL] [Abstract][Full Text] [Related]
6. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
7. The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study.
Sibbel S; Sato R; Hunt A; Turenne W; Brunelli SM
BMC Nephrol; 2016 Dec; 17(1):199. PubMed ID: 27955633
[TBL] [Abstract][Full Text] [Related]
8. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.
Mau LW; Liu J; Qiu Y; Guo H; Ishani A; Arneson TJ; Gilbertson DT; Dunning SC; Collins AJ
Am J Kidney Dis; 2010 Mar; 55(3):549-57. PubMed ID: 20116913
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis of renal replacement therapies in Finland.
Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
[TBL] [Abstract][Full Text] [Related]
13. The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease.
Lefebvre P; Duh MS; Mody SH; Bookhart B; Piech CT
Dis Manag; 2007 Feb; 10(1):37-45. PubMed ID: 17309363
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary predialysis education reduced the inpatient and total medical costs of the first 6 months of dialysis in incident hemodialysis patients.
Yu YJ; Wu IW; Huang CY; Hsu KH; Lee CC; Sun CY; Hsu HJ; Wu MS
PLoS One; 2014; 9(11):e112820. PubMed ID: 25398129
[TBL] [Abstract][Full Text] [Related]
15. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment].
Malberti F; Ravani P
G Ital Nefrol; 2003; 20(2):127-32. PubMed ID: 12746797
[TBL] [Abstract][Full Text] [Related]
16. Effect of comorbidity on the increased mortality associated with early initiation of dialysis.
Kazmi WH; Gilbertson DT; Obrador GT; Guo H; Pereira BJ; Collins AJ; Kausz AT
Am J Kidney Dis; 2005 Nov; 46(5):887-96. PubMed ID: 16253729
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of global costs for maintenance of patients with ESRD.
Ploth DW; Shepp PH; Counts C; Hutchison F
Am J Kidney Dis; 2003 Jul; 42(1):12-21. PubMed ID: 12830452
[TBL] [Abstract][Full Text] [Related]
18. Excluded from universal coverage: ESRD patients not covered by Medicare.
Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ
Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372
[TBL] [Abstract][Full Text] [Related]
19. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis.
Liao M; Li Y; Kianifard F; Obi E; Arcona S
BMC Nephrol; 2016 Mar; 17():25. PubMed ID: 26936756
[TBL] [Abstract][Full Text] [Related]
20. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
